• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

COMPREHENSIVE ANALYSIS OF PROLIFERATIVE RESPONSES IN MURINE JEJUNAL CRYPT DURING MULTIPLE FRACTIONATION

Research Project

Project/Area Number 09670908
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionHIROSAKI UNIVERSITY

Principal Investigator

ABE Yoshinao  SCHOOL OF MEDICINE PROFESSOR, 医学部, 教授 (10167950)

Co-Investigator(Kenkyū-buntansha) MATSUTANI Hideya  SCHOOL OF MEDICINE RESEARCH ASSISTANT, 医学部, 助手 (30241483)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 1998: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1997: ¥1,900,000 (Direct Cost: ¥1,900,000)
KeywordsJEJUNAL CRYPT / FRACTIONATION / REPOPULATION / CELL LOSS FACTOR / APOPTOSIS / POTENTIAL DOUBLING TIME / MULTIPLE FRACTIONS A DAY / PROLIFEARTIVE RESPONSE / 小腸線窩 / 3H-チミジン / 移行時間
Research Abstract

To improve the efficacy of radiation therapy, the cause of radioresistance due to tumor repopulation during fractionation should be solved. Through these fiscal years of 1997-1998, we obtained the following experimental data regarding proliferative responses during fractionation in murine jejunal crypt. Through the experiments, fraction (fx) size was 2 Gy. 1) Clonogenic cells in the crypt were rapidly repopulating during fractionation and the extent of repopulation was dependent on fraction size a day : 2-fx-a-day treatment induced more than 1-fx-a-day treatment. 2) Number of cells in the crypt increased significantly during 2-ft-a-day treatment compared with 1-fx-a-day treatment. 3) Both treatments caused faster potential doubling time (Tpot) during fractionation and did not vary the Tpot. 4) Transition time from crypt to villi showed slower during 2-fx- a-day treatment than 1-ft-a-day treatment ; i.e. decreased cell loss factor. 5) Number of apoptosis was more increased during 2-fx-a-day treatment than 1-fx-a-day treatment.
To summarize these results, repopulation during fractionation inmurine jejunal crypt was observed and was dependent on the fraction number a day. Such proliferative responses increased the number of cells in the crypt and, thus, maintained the number of clonogenic cells in the crypt. Shortening of Tpot and decreased cell loss factor is the causes of repopulation during fractionation. These papaers are in prepare for publications.
Clinical data regarding repopulation were also reported inrelationship to such as overall treatment time, accelerated fractionation and DNA ploidy. Another clinical data suggesting importance in timing of chemotherapy during fractionations which caused an excellent results were also reported.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Y.Abe et al.: "A phase II study of cisplatin, oral administration of etoposide, OK-432 and radiation therapy for inoperable stage III non-small cell lung cancer." Int J Clin Oncol. 3. 365-369 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y.Mariya et al.: "The impact of biologically effective dose corrected for overall treatment time upon tumor control of stage I and II laryngeal cancers." J Jpn Soc Ther Radiol Oncol. 10. 215-222 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y.Mariya et al.: "Enhanced regeneration response of laryngeal and hypopharyngeal mucosa with accelerated hyperfractionated radiation therapy for glottic cancers." Radiat Med. 16. 469-472 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 真里谷靖他: "舌癌T1T2症例の226Ra組織内照射治療成績および予後測定因子としてのploidy, potential doubling timeの臨床的意義." 日本放射線腫瘍学会誌. 9. 15-24 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 場崎 潔他: "マウス小腸腺窩細胞の分裂遅延、アポトーシス高感受性細胞群生存率およびコロニー形成能をエンドポイントとした炭素線ビームのRBE." 日本放射線腫瘍学会誌. 10. 27-33 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 青木昌彦他: "頭頚部癌照射例におけるflow cytometryによる核DNA量解析." 癌の臨床. 44. 195-196 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 阿部由直他: "田中他編「癌の放射線治療」金芳堂" 「放射線治療における4(5)R」, 179-189 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 福田 寛他: "田中他編「癌の放射線治療」金芳堂" [PETによる放射線感受性予測」, 154-161 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y.ABE,J.TAKAHASHI,H.FUKUDA,S.ONO,S.YOSHIOKA,T.AKAIZAWA,K.KUBOTA,K.YAMADA,T.TAKAHASHI,K.OHKUDA,N.ASOH,M.YONECHI,N.MAEHIRA,Y.MARIYA AND M.AOKI: "A PHASE II STUDY OF CISPLATIN,ORAL ADMINISTRATION OF ETOPOSIDE,OK-432 AND RADIATION THERAPY FOR INOPERABLE STAGE III NON-SMALL CELL LUNG CANCER." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 3-6. 365-369 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y.MARIYA,M.AOKI,A.ANBAI,H.MATSUKURA,Y.ABE,T.KIMURA,K.MATSUDA,H.OHNUMA,S.YOKOYAMA: "RESPONSE OF UNRESECTABLE PANCREATIC CANCER TO INTRAOPERATIVE RADIOTHERAPY." RADIATION MEDICINE. 16-3. 195-200 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y.MARIYA,S.WATANABE,K.KATTOU,Y.ABE,M.AOKI,A.ANBAI,H.MATSUKURA,K.BASAKI,M.ABO: "THE IMPACT OF BIOLOGICALLY EFFECTIVE DOSE CORRECTED FOR OVERALL TREATMENT TIME UPON TUMOR CONTROL OF STAGE I AND II LARYNGEAL CANCERS." JOURNAL OF JAPANESE SOCIETY OF THERAPEUTIC RADIOLOGY ONCOLOGY. 10-3. 215-222 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y.MARIYA,H.MATSUTANI,Y.ABE,S.NAKAJI: "ENHANCED REGENERATION RESPONSE OF LARYNGEAL AND HYPOPHARYNGEAL MUCOSA WITH ACCELERATED HYPERFRACTIONATED RADIATION THERAPY FOR GLOTTIC CANCERS." RADIATION MEDICINE. 16-6. 469-472 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y.Abe: "A phase II of cisplatin,oral administration of etoposide,OK-432 and radiation therapy for inoperable stage III non-small cell lung cancer." Int J clin Oncol. 3. 365-369 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Y.Mariya: "The impact of biologically effective dose corrected for overall treatment tうne upon tumor control of stage I and II layngeal cancers." J JPN Soc Ther Radiol Oncol. 10. 215-222 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Y.Mariya: "Enhanced regeneration response of layngeal and hypopharyngeal mucosa with accelerated hyperfractionated radiation therapy for glottic cancers." Radiat Med. 16. 469-472 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 場崎 潔: "マウス小腸腺窩細胞の分裂遅延、アポトーシス高感受性細胞群生存率およびコロニー形成能をエンドポイントとした炭素線ビームのRBE." 日本放射線腫瘍学会誌. 10. 27-33 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 青木昌彦: "頭頚部癌照射例におけるflow cytometryによる核DNA量解析" 癌の臨床. 44. 195-196 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 阿部由直: 田中他編 癌の放射線治療 金芳堂. 179-189 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 青木昌彦 他: "頭頚部癌照射例におけるfloo cytornetryによる核DNA量解析" 癌の臨床. 44・2. 195-196 (1998)

    • Related Report
      1997 Annual Research Report
  • [Publications] 鈴木 聡 他: "放射線照射後急性期における肺胞上皮を介したNa^+と水分輸送能の変化" 日本胸部疾患学会雑誌. 35. 167-172 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi